Search Results
University of Alabama at Birmingham, Department of Surgery, Division of Surgical Oncology, Birmingham, Alabama, USA
Search for other papers by Sarah B Bateni in
Google Scholar
PubMed
Susan Leslie Clinic for Neuroendocrine Tumors, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Clinical evaluative sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada
Search for other papers by Natalie G Coburn in
Google Scholar
PubMed
Susan Leslie Clinic for Neuroendocrine Tumors, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Search for other papers by Calvin Law in
Google Scholar
PubMed
Susan Leslie Clinic for Neuroendocrine Tumors, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Clinical evaluative sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada
Search for other papers by Simron Singh in
Google Scholar
PubMed
Susan Leslie Clinic for Neuroendocrine Tumors, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Clinical evaluative sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada
Search for other papers by Sten Myrehaug in
Google Scholar
PubMed
Susan Leslie Clinic for Neuroendocrine Tumors, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Clinical evaluative sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada
Search for other papers by Angela Assal in
Google Scholar
PubMed
Susan Leslie Clinic for Neuroendocrine Tumors, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Clinical evaluative sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada
Search for other papers by Julie Hallet in
Google Scholar
PubMed
Introduction Neuroendocrine tumors (NETs) are rare tumors originating from the neuroendocrine system along the gastrointestinal tract and lungs ( Yao et al. 2008 , Hallet et al. 2015 , Dasari et al. 2017 , 2018 ). Although
Search for other papers by Germano Gaudenzi in
Google Scholar
PubMed
Search for other papers by Silvia Carra in
Google Scholar
PubMed
Search for other papers by Alessandra Dicitore in
Google Scholar
PubMed
Search for other papers by Maria Celeste Cantone in
Google Scholar
PubMed
Department of Clinical Sciences and Community Health (DISCCO), University of Milan, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Department of Clinical Sciences and Community Health (DISCCO), University of Milan, Milan, Italy
Search for other papers by Giovanni Vitale in
Google Scholar
PubMed
Introduction Neuroendocrine tumors (NETs) represent a broad class of neoplasms originating from neuroendocrine cells. NETs can cause a wide array of symptoms depending on the type of tumor, its location and the production of several factors
Search for other papers by Jaydira Del Rivero in
Google Scholar
PubMed
Search for other papers by Josh Mailman in
Google Scholar
PubMed
Search for other papers by Michael W Rabow in
Google Scholar
PubMed
Search for other papers by Jennifer A Chan in
Google Scholar
PubMed
Search for other papers by Sarah Creed in
Google Scholar
PubMed
Search for other papers by Hagen F Kennecke in
Google Scholar
PubMed
Search for other papers by Janice Pasieka in
Google Scholar
PubMed
Search for other papers by Jennifer Zuar in
Google Scholar
PubMed
Search for other papers by Simron Singh in
Google Scholar
PubMed
Search for other papers by Lauren Fishbein in
Google Scholar
PubMed
lung cancer ( Temel et al. 2010 , Ferrell et al. 2017 ). Patients with neuroendocrine tumors (NETs) represent a unique population, as many have metastatic disease at presentation, yet can have prolonged survival rates for years. Since these
Search for other papers by Nicole Panarelli in
Google Scholar
PubMed
Search for other papers by Kathrin Tyryshkin in
Google Scholar
PubMed
Search for other papers by Justin Jong Mun Wong in
Google Scholar
PubMed
Search for other papers by Adrianna Majewski in
Google Scholar
PubMed
Search for other papers by Xiaojing Yang in
Google Scholar
PubMed
Search for other papers by Theresa Scognamiglio in
Google Scholar
PubMed
Search for other papers by Michelle Kang Kim in
Google Scholar
PubMed
Search for other papers by Kimberly Bogardus in
Google Scholar
PubMed
Search for other papers by Thomas Tuschl in
Google Scholar
PubMed
Search for other papers by Yao-Tseng Chen in
Google Scholar
PubMed
HHMI, Laboratory of RNA Molecular Biology, The Rockefeller University, New York, New York, USA
Search for other papers by Neil Renwick in
Google Scholar
PubMed
Introduction Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are increasingly common and clinically diverse neoplasms ( Yao et al . 2008 , Lawrence et al . 2011 ) that are challenging to evaluate histologically ( Klimstra 2016
Aix-Marseille Université, Institut National de la Santé et de la Recherche Médicale (INSERM), U1251, Marseille Medical Genetics (MMG), Marseille, France
Department of Endocrinology, Assistance Publique – Hôpitaux de Marseille (AP-HM), Hôpital de la Conception, Centre de Référence des Maladies Rares Hypophysaires HYPO, Marseille, France
Search for other papers by Thomas Cuny in
Google Scholar
PubMed
Search for other papers by Wouter de Herder in
Google Scholar
PubMed
Department of Endocrinology, Assistance Publique – Hôpitaux de Marseille (AP-HM), Hôpital de la Conception, Centre de Référence des Maladies Rares Hypophysaires HYPO, Marseille, France
Search for other papers by Anne Barlier in
Google Scholar
PubMed
Search for other papers by Leo J Hofland in
Google Scholar
PubMed
Introduction Human gastroenteropancreatic neuroendocrine tumors (GEP-NETs) represent a heterogeneous group of tumors emerging from cells producing glycopeptides and biogenic amines ( Klöppel 2011 ). They account for approximately 0.5% of all
Center for Oncological Research, University of Antwerp, Antwerp, Belgium
Search for other papers by Matthias Beyens in
Google Scholar
PubMed
Center for Oncological Research, University of Antwerp, Antwerp, Belgium
Section of Endocrinology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands
Search for other papers by Timon Vandamme in
Google Scholar
PubMed
Search for other papers by Marc Peeters in
Google Scholar
PubMed
Center for Oncological Research, University of Antwerp, Antwerp, Belgium
Search for other papers by Guy Van Camp in
Google Scholar
PubMed
Center for Oncological Research, University of Antwerp, Antwerp, Belgium
Search for other papers by Ken Op de Beeck in
Google Scholar
PubMed
regulating cell growth, proliferation, survival and protein synthesis in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) ( Missiaglia et al. 2010 , Jiao et al. 2011 , Kasajima et al. 2011 ). GEP-NETs include small intestinal NETs (siNETs) and
Laboratory of Geriatric and Oncologic Neuroendocrinology Research, Istituto Auxologico Italiano IRCCS, Milan, Italy
Search for other papers by Giovanni Vitale in
Google Scholar
PubMed
Search for other papers by Alessandra Dicitore in
Google Scholar
PubMed
Search for other papers by Concetta Sciammarella in
Google Scholar
PubMed
Search for other papers by Sergio Di Molfetta in
Google Scholar
PubMed
Search for other papers by Manila Rubino in
Google Scholar
PubMed
Search for other papers by Antongiulio Faggiano in
Google Scholar
PubMed
Search for other papers by Annamaria Colao in
Google Scholar
PubMed
Introduction Neuroendocrine tumors (NETs) comprise a heterogeneous group of neoplasms in most cases with a low rate of growth and sometimes able to produce and secrete several hormones that drive forward specific clinical syndromes, leading to
Department of Clinical Sciences and Community Health (DISCCO), Laboratory of Endocrine and Metabolic Research, Department of Biosciences, Endocrinology Unit, University of Milan, Milan, Italy
Search for other papers by Giovanni Vitale in
Google Scholar
PubMed
Search for other papers by Germano Gaudenzi in
Google Scholar
PubMed
Search for other papers by Alessandra Dicitore in
Google Scholar
PubMed
Search for other papers by Franco Cotelli in
Google Scholar
PubMed
Search for other papers by Diego Ferone in
Google Scholar
PubMed
Department of Clinical Sciences and Community Health (DISCCO), Laboratory of Endocrine and Metabolic Research, Department of Biosciences, Endocrinology Unit, University of Milan, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
a model in cancer research, focusing on potential applications in neuroendocrine tumors (NETs). Zebrafish as a cancer model Although fish do not have certain organs found in mammals (breast, prostate, and lung), zebrafish spontaneously develops
Search for other papers by Nitya Raj in
Google Scholar
PubMed
Search for other papers by Youyun Zheng in
Google Scholar
PubMed
Search for other papers by Haley Hauser in
Google Scholar
PubMed
Search for other papers by Joanne Chou in
Google Scholar
PubMed
Search for other papers by Johnathan Rafailov in
Google Scholar
PubMed
Search for other papers by Jad Bou-Ayache in
Google Scholar
PubMed
Search for other papers by Peter Sawan in
Google Scholar
PubMed
Search for other papers by Jamie Chaft in
Google Scholar
PubMed
Search for other papers by Jennifer Chan in
Google Scholar
PubMed
Search for other papers by Kimberly Perez in
Google Scholar
PubMed
Search for other papers by Charles Rudin in
Google Scholar
PubMed
Search for other papers by Laura Tang in
Google Scholar
PubMed
Search for other papers by Diane Reidy-Lagunes in
Google Scholar
PubMed
Introduction Well-differentiated neuroendocrine tumors (WDNETs) arising from varying anatomic sites are biologically different, with the tumor embryologic origin (foregut, midgut, hindgut) important for disease classification and to stratify
Search for other papers by J R Strosberg in
Google Scholar
PubMed
Search for other papers by J A Chan in
Google Scholar
PubMed
Search for other papers by D P Ryan in
Google Scholar
PubMed
Search for other papers by J A Meyerhardt in
Google Scholar
PubMed
Search for other papers by C S Fuchs in
Google Scholar
PubMed
Search for other papers by T Abrams in
Google Scholar
PubMed
Search for other papers by E Regan in
Google Scholar
PubMed
Search for other papers by R Brady in
Google Scholar
PubMed
Search for other papers by J Weber in
Google Scholar
PubMed
Search for other papers by T Campos in
Google Scholar
PubMed
Search for other papers by L K Kvols in
Google Scholar
PubMed
Search for other papers by M H Kulke in
Google Scholar
PubMed
Introduction Neuroendocrine tumors (NETs) comprise a heterogeneous spectrum of neoplasms. NETs are commonly subclassified into two broad subgroups according to their site of origin: pancreatic NETs (pNETs) are thought to arise from the endocrine